Prebiotic galacto-oligosaccharides improve gut microbiota and secretory immunoglobulins in Sprague Dawley rats

Authors:

Abstract
Prebiotic galacto-oligosaccharides (GOS) impart a wide array of health effects on gut microbiota and subsequently improve the host's immunological response; however, their prebiotic potential is affected by several factors, including dose, duration, composition, etc. This study used commercial GOS to evaluate their impact on selected gut microbial populations and secretory immunoglobulin A (IgA). The GOS were supplemented in the basal diet (1% w/w) fed to male Sprague–Dawley rats. Physical parameters such as body weight and organ weights, serum biochemical analysis, and cecal microbial population were determined after 4 weeks of intervention. GOS alone significantly increased bifidobacteria and lactobacilli growth in the intervention group (p < 0.05) without changing total bacteria after 4 weeks. Clostridia and coliform counts were significantly reduced only in the GOS group. Bifidobacteria also improved significantly over time, whereas all other microbes remained unaffected by time alone or by diet. The parameters of blood chemistry, serum glucose, AST and ALT, TC, LDL, and TG were not affected significantly (p > 0.05) by GOS addition in the diet; however, HDL improved significantly. GOS significantly improved sIgA in cecal and ileal contents (p < 0.05) compared to the control group. These findings indicate that GOS supplementation may exert prebiotic effects by increasing selected beneficial bacterial populations and intestinal sIgA levels in animal models.

This publication has 40 references indexed in Scilit: